48 studies found for:    Open Studies | "Gastrointestinal Stromal Tumors"
Show Display Options
Rank Status Study
21 Recruiting Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy
Conditions: Gastrointestinal Stromal Tumor;   Major Gastrectomy
Intervention: Dietary Supplement: cola
22 Recruiting Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: Sunitinib;   Drug: Regorafenib
23 Not yet recruiting Masitinib vs Placebo - Phase III Study to Compare the Efficacy and Safety of Masitinib to Placebo in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence
Condition: Gastro-Intestinal Stromal Tumour
Interventions: Drug: Masitinib;   Drug: Placebo
24 Unknown  A Retrospective Study of C-kit Mutation Status in Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib.
Condition: Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib
Intervention: Procedure: Tumor biopsies
25 Recruiting A Trial of Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Paclitaxel
26 Recruiting GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Condition: Gastro-intestinal Stromal Tumor
Interventions: Procedure: Vena puncture for blood collection;   Procedure: Tumor biopsy
27 Recruiting Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Other: follow up
28 Recruiting Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation
Condition: Gastrointestinal Stromal Tumour (GIST)
Intervention: Drug: regorafenib
29 Unknown  Caphosol in Oral Mucositis Due to Targeted Therapy
Conditions: Oral Mucositis;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Gastrointestinal Stromal Tumors
Interventions: Other: supersaturated calcium-phosphate rinse;   Other: sodium chloride 0.9 %
30 Not yet recruiting Ph II CABOGIST in GIST
Condition: Metastatic Gastrointestinal Stromal Tumor
Intervention: Drug: cabozantinib
31 Recruiting Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy
Condition: Gastrointestinal Stromal Tumor
Intervention:
32 Recruiting A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumors;   Aggressive Systemic Mastocytosis;   Advanced Cancers
Intervention: Drug: DCC-2618
33 Unknown  ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors
Conditions: Upper Gastrointestinal Submucosal Tumors (SMTs);   Gastrointestinal Stromal Tumors (GISTs);   Leiomyoma
Interventions: Procedure: ESTD;   Procedure: VATS
34 Recruiting Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery
Conditions: Complications of Surgical Procedures;   Surgical Site Infection;   Gastric Cancer;   Colorectal Cancer;   Gastrointestinal Stromal Tumor;   Inflammatory Bowel Disease;   Diverticula
Interventions: Procedure: Laparoscopic surgery;   Device: Skin sealant
35 Unknown  Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
Conditions: Renal Cell Carcinoma;   Gastrointestinal Stromal Tumor
Interventions: Drug: usage oral angiogenesis inhibitor;   Drug: stop oral angiogenesis inhibitor
36 Recruiting Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: regorafenib
37 Recruiting Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)
Conditions: Gastric Neoplasms;   Gastrointestinal Stromal Tumors
Intervention: Device: GERDX(TM)
38 Recruiting The Oncopanel Pilot (TOP) Study
Conditions: Colorectal Cancer Metastatic;   Advanced Non-Small Cell Lung Carcinoma;   Advanced Melanoma;   Gastrointestinal Stromal Tumors;   Patients With Diagnosed Malignancies Being Considered for Clinical Trials
Intervention:
39 Recruiting Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: imatinib
40 Recruiting TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
Conditions: Pancreatic Cancer;   Colorectal Cancer;   Rectal Cancer;   Gastric Cancer;   Esophageal Cancer;   Gastrointestinal Stromal Tumor (GIST)
Interventions: Drug: TGR-1202;   Drug: nab-paclitaxel + gemcitabine;   Drug: Oxaliplatin + Folinic acid + Fluorouracil;   Drug: Oxaliplatin + Folinic acid + Fluorouracil + Bevacizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-48) Show next page of results    Last Page
Indicates status has not been verified in more than two years